title: Carboquone combined with methotrexate and 5-fluorouracil for recurrent and advanced ovarian cancer.
authors.forename: J U
authors.initials: JU
authors.lastname: Mäenpää
authors.forename: E
authors.initials: E
authors.lastname: Heinonen
authors.forename: P
authors.initials: P
authors.lastname: Karnani
authors.forename: A
authors.initials: A
authors.lastname: Kauppila
authors.forename: T
authors.initials: T
authors.lastname: Kuoppala
authors.forename: T
authors.initials: T
authors.lastname: Salmi
authors.forename: P
authors.initials: P
authors.lastname: Sipilä
authors.forename: U
authors.initials: U
authors.lastname: Nieminen
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002225:Carbazilquinone / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D002225:Carbazilquinone; D005472:Fluorouracil; D008727:Methotrexate